Advertisement
Screener

Exelixis Inc (EXEL) Basic Shares Outstanding (Weighted Average)

Exelixis Inc Basic Shares Outstanding (Weighted Average)

Exelixis Inc (EXEL) reported Basic Shares Outstanding (Weighted Average) of 250.81 million shares for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05

  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-07-03 was 250.81M shares, a 7.99% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-04-03 was 258.33M shares, a 7.34% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-01-02 was 266.46M shares, a 6.35% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2025-10-03 was 268.42M shares, a 6.02% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2026 was 271.57M shares, a 6.37% decline from fiscal 2025.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2025 was 290.03M shares, a 8.84% decline from fiscal 2023.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2023 was 318.15M shares, a 1.05% decline from fiscal 2022.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2022 was 321.53M shares, a 2.11% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 month
2026-07-03250.81M shares
10-Q · filed 2026-08-05
254.57M shares
10-Q · filed 2026-08-05
258.53M shares
derived: average of 3 quarters · filed 2026-08-05
261.00M shares
derived: average of 4 quarters · filed 2026-08-05
2026-04-03258.33M shares
10-Q · filed 2026-05-05
262.39M shares
derived: average of 2 quarters · filed 2026-05-05
264.40M shares
derived: average of 3 quarters · filed 2026-05-05
266.45M shares
derived: average of 4 quarters · filed 2026-08-05
2026-01-02266.46M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
267.44M shares
derived: average of 2 quarters · filed 2026-02-10
269.15M shares
derived: average of 3 quarters · filed 2026-08-05
271.57M shares
10-K · filed 2026-02-10
2025-10-03268.42M shares
10-Q · filed 2025-11-04
270.50M shares
derived: average of 2 quarters · filed 2026-08-05
273.27M shares
10-Q · filed 2025-11-04
276.08M shares
derived: average of 4 quarters · filed 2026-08-05
2025-07-04272.58M shares
10-Q · filed 2026-08-05
275.69M shares
10-Q · filed 2026-08-05
278.64M shares
derived: average of 3 quarters · filed 2026-08-05
280.38M shares
derived: average of 4 quarters · filed 2026-08-05
2025-04-04278.80M shares
10-Q · filed 2026-05-05
281.66M shares
derived: average of 2 quarters · filed 2026-05-05
282.98M shares
derived: average of 3 quarters · filed 2026-05-05
284.54M shares
derived: average of 4 quarters · filed 2026-05-05
2025-01-03284.52M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
285.07M shares
derived: average of 2 quarters · filed 2026-02-10
286.45M shares
derived: average of 3 quarters · filed 2026-02-10
290.03M shares
10-K · filed 2026-02-10
2024-09-27285.62M shares
10-Q · filed 2025-11-04
287.42M shares
derived: average of 2 quarters · filed 2025-11-04
291.87M shares
10-Q · filed 2025-11-04
296.02M shares
derived: average of 4 quarters · filed 2026-02-10
2024-06-28289.22M shares
10-Q · filed 2025-07-28
294.99M shares
10-Q · filed 2025-07-28
299.49M shares
derived: average of 3 quarters · filed 2026-02-10
303.49M shares
derived: average of 4 quarters · filed 2026-02-10
2024-03-29300.76M shares
10-Q · filed 2025-05-13
304.62M shares
derived: average of 2 quarters · filed 2026-02-10
308.25M shares
derived: average of 3 quarters · filed 2026-02-10
312.24M shares
derived: average of 4 quarters · filed 2026-02-10
2023-12-29308.49M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
311.99M shares
derived: average of 2 quarters · filed 2026-02-10
316.06M shares
derived: average of 3 quarters · filed 2026-02-10
318.15M shares
10-K · filed 2026-02-10
2023-09-29315.50M shares
10-Q · filed 2024-10-29
319.85M shares
derived: average of 2 quarters · filed 2024-10-29
321.37M shares
10-Q · filed 2024-10-29
321.84M shares
derived: average of 4 quarters · filed 2025-02-11
2023-06-30324.20M shares
10-Q · filed 2024-08-06
324.31M shares
10-Q · filed 2024-08-06
323.96M shares
derived: average of 3 quarters · filed 2025-02-11
323.51M shares
derived: average of 4 quarters · filed 2025-02-11
2023-03-31324.42M shares
10-Q · filed 2024-04-30
323.84M shares
derived: average of 2 quarters · filed 2025-02-11
323.27M shares
derived: average of 3 quarters · filed 2025-02-11
322.74M shares
derived: average of 4 quarters · filed 2025-02-11
2022-12-30323.26M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
322.70M shares
derived: average of 2 quarters · filed 2025-02-11
322.17M shares
derived: average of 3 quarters · filed 2025-02-11
321.53M shares
10-K · filed 2025-02-11
2022-09-30322.15M shares
10-Q · filed 2023-11-01
321.63M shares
derived: average of 2 quarters · filed 2023-11-01
320.95M shares
10-Q · filed 2023-11-01
320.10M shares
derived: average of 4 quarters · filed 2024-02-06
2022-07-01321.12M shares
10-Q · filed 2023-08-01
320.35M shares
10-Q · filed 2023-08-01
319.42M shares
derived: average of 3 quarters · filed 2024-02-06
318.41M shares
derived: average of 4 quarters · filed 2024-02-06
2022-04-01319.58M shares
10-Q · filed 2023-05-09
318.57M shares
derived: average of 2 quarters · filed 2024-02-06
317.51M shares
derived: average of 3 quarters · filed 2024-02-06
316.66M shares
derived: average of 4 quarters · filed 2024-02-06
2021-12-31317.57M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
316.47M shares
derived: average of 2 quarters · filed 2024-02-06
315.69M shares
derived: average of 3 quarters · filed 2024-02-06
314.88M shares
10-K · filed 2024-02-06
2021-10-01315.38M shares
10-Q · filed 2022-11-01
314.75M shares
derived: average of 2 quarters · filed 2022-11-01
313.99M shares
10-Q · filed 2022-11-01
313.19M shares
derived: average of 4 quarters · filed 2023-02-07
2021-07-02314.12M shares
10-Q · filed 2022-08-09
313.30M shares
10-Q · filed 2022-08-09
312.45M shares
derived: average of 3 quarters · filed 2023-02-07
311.62M shares
derived: average of 4 quarters · filed 2023-02-07
2021-04-02312.47M shares
10-Q · filed 2022-05-10
311.62M shares
derived: average of 2 quarters · filed 2023-02-07
310.79M shares
derived: average of 3 quarters · filed 2023-02-07
310.04M shares
derived: average of 4 quarters · filed 2023-02-07
2021-01-01310.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
309.94M shares
derived: average of 2 quarters · filed 2023-02-07
309.23M shares
derived: average of 3 quarters · filed 2023-02-07
308.27M shares
10-K · filed 2023-02-07
2020-10-02309.12M shares
10-Q · filed 2021-11-02
308.46M shares
derived: average of 2 quarters · filed 2021-11-02
307.44M shares
10-Q · filed 2021-11-02
306.66M shares
derived: average of 4 quarters · filed 2022-02-18
2020-07-03307.81M shares
10-Q · filed 2021-08-05
306.60M shares
10-Q · filed 2021-08-05
305.84M shares
derived: average of 3 quarters · filed 2022-02-18
305.20M shares
derived: average of 4 quarters · filed 2022-02-18
2020-04-03305.39M shares
10-Q · filed 2021-05-06
304.86M shares
derived: average of 2 quarters · filed 2022-02-18
304.33M shares
derived: average of 3 quarters · filed 2022-02-18
303.80M shares
derived: average of 4 quarters · filed 2022-02-18
2020-01-03304.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
303.80M shares
derived: average of 2 quarters · filed 2022-02-18
303.26M shares
derived: average of 3 quarters · filed 2022-02-18
302.58M shares
10-K · filed 2022-02-18
2019-09-27303.27M shares
10-Q · filed 2020-11-05
302.73M shares
derived: average of 2 quarters · filed 2020-11-05
302.00M shares
10-Q · filed 2020-11-05
301.12M shares
derived: average of 4 quarters · filed 2020-11-05
2019-06-28302.19M shares
10-Q · filed 2020-08-06
301.37M shares
10-Q · filed 2020-08-06
300.40M shares
derived: average of 3 quarters · filed 2020-08-06
299.90M shares
derived: average of 4 quarters · filed 2020-08-06
2019-03-29300.54M shares
10-Q · filed 2020-05-05
299.50M shares
derived: average of 2 quarters · filed 2020-05-05
299.14M shares
derived: average of 3 quarters · filed 2020-05-05
298.69M shares
derived: average of 4 quarters · filed 2020-05-05
2018-12-28298.47M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
298.44M shares
derived: average of 2 quarters · filed 2020-02-25
298.07M shares
derived: average of 3 quarters · filed 2020-02-25
297.89M shares
10-K · filed 2021-02-11
2018-09-28298.42M shares
10-Q · filed 2019-10-30
297.88M shares
derived: average of 2 quarters · filed 2019-10-30
297.70M shares
10-Q · filed 2019-10-30
297.05M shares
derived: average of 4 quarters · filed 2020-02-25
2018-06-29297.34M shares
10-Q · filed 2019-07-31
296.87M shares
10-Q · filed 2019-07-31
296.59M shares
derived: average of 3 quarters · filed 2020-02-25
296.01M shares
derived: average of 4 quarters · filed 2020-02-25
2018-03-30296.42M shares
10-Q · filed 2019-05-01
296.22M shares
derived: average of 2 quarters · filed 2020-02-25
295.57M shares
derived: average of 3 quarters · filed 2020-02-25
2017-12-29296.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
295.15M shares
derived: average of 2 quarters · filed 2020-02-25
293.59M shares
10-K · filed 2020-02-25
2017-09-30294.27M shares
10-Q · filed 2017-11-01
292.78M shares
10-Q · filed 2017-11-01
2017-09-29294.27M shares
10-Q · filed 2018-11-01
293.73M shares
derived: average of 2 quarters · filed 2018-11-01
292.78M shares
10-Q · filed 2018-11-01
2017-06-30293.19M shares
10-Q · filed 2018-08-01
292.03M shares
10-Q · filed 2017-08-02
2017-03-31290.87M shares
10-Q · filed 2017-05-01
2016-12-30250.53M shares
10-K · filed 2019-02-22
2016-09-30256.32M shares
10-Q · filed 2017-11-01
242.81M shares
derived: average of 2 quarters · filed 2017-11-01
238.02M shares
10-Q · filed 2017-11-01
2016-06-30229.31M shares
10-Q · filed 2017-08-02
228.86M shares
10-Q · filed 2017-08-02
2016-03-31228.30M shares
10-Q · filed 2017-05-01
2016-01-01209.23M shares
10-K · filed 2018-02-26
2013-12-31184.06M shares
10-K · filed 2014-02-20
2012-12-31183.60M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
174.98M shares
derived: average of 2 quarters · filed 2014-02-20
160.14M shares
10-K · filed 2014-02-20
2012-09-30166.35M shares
10-Q · filed 2012-11-07
152.32M shares
10-Q · filed 2012-11-07
2011-12-31133.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
131.47M shares
derived: average of 2 quarters · filed 2014-02-20
126.02M shares
10-K · filed 2014-02-20
2011-09-30129.15M shares
10-Q · filed 2012-11-07
129.15K shares
10-Q · filed 2011-10-27
123.43M shares
10-Q · filed 2012-11-07
123.43K shares
10-Q · filed 2011-10-27
2010-12-31433.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
216.94M shares
derived: average of 2 quarters · filed 2013-02-21
108.52M shares
10-K · filed 2013-02-21
2010-09-30108.67K shares
10-Q · filed 2011-10-27
108.37K shares
10-Q · filed 2011-10-27
2009-12-31107.07M shares
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78